Latest News - Research and Publications

Tuesday, October 17, 2017 | PracticalDermatology.com, Research and Publications, American Academy of Dermatology

Timing of Melanoma Diagnosis, Treatment Can Mean Life or Death

The sooner melanoma patients are treated, the better their survival, particularly for stage I melanoma, according to a new study from the Cleveland Clinic. The research appears online today in the …

Read the full story

Monday, October 16, 2017 | PracticalDermatology.com, Research and Publications, National Rosacea Society

National Rosacea Society Awards New Grants; Call for 2018 Proposals

The National Rosacea Society (NRS) awarded funding for three new studies, in addition to continuing support for three ongoing studies, as part of its research grants program. Dr. Benjamin Kaffenber…

Read the full story

Monday, October 16, 2017 | PracticalDermatology.com, Research and Publications

Ortho Dermatologics: Long-term Efficacy Data for Siliq

Siliq™ (brodalumab) injection provided sustained high levels of skin clearance (PASI 100) over more than two years in patients with moderate-to-severe psoriasis, according to data presented at t…

Read the full story

Friday, October 06, 2017 | PracticalDermatology.com, Research and Publications, American Society for Dermatologic Surgery

Two New Grants Continue Dr. Fredric S. Brandt’s Legacy

Two American Society for Dermatologic Surgery members received grants totaling more than $84,000 from the Fredric S. Brandt, MD, Innovations in Aesthetics Fellowship Fund at the 2017 ASDS Annual Meeti…

Read the full story

Friday, October 06, 2017 | PracticalDermatology.com, Research and Publications, American Society for Dermatologic Surgery

ASDS Cutting Edge Research Grants Awarded

The American Society for Dermatologic Surgery (ASDS) awarded a total of $96,669 to eight new research projects as part of rhe Cutting Edge Research Grant program The program was introduced in 1999 …

Read the full story

Wednesday, October 04, 2017 | PracticalDermatology.com, Research and Publications, Melanoma

Medicaid Patients May Receive Less Timely Melanoma Surgery

Delays in melanoma surgery may vary by insurance type, according to research in JAMA Dermatology. While Medicaid patients had the highest likelihood of delays, significant proportions of Medicare a…

Read the full story

Wednesday, October 04, 2017 | Healthcare Trends, Research and Publications

ISHRS: Hair Restoration Surgery at All-Time High

Hair restoration is having a moment. The worldwide volume of surgical hair restoration procedures performed from 2014 to 2016 rose 60 percent, with 635,189 procedures performed worldwide in 2016,&n…

Read the full story

Monday, October 02, 2017 | PracticalDermatology.com, Research and Publications

Study IDs Racial and Ethnic Disparities in Pediatric Eczema Treatment

White children in the US are more likely to see a doctor for treatment of eczema than black children, despite the fact that the disease is likely more severe among minorities. Research from the Per…

Read the full story

Wednesday, September 27, 2017 | Research and Publications

Warning: Sindoor Used in Hindu Ceremonies May Contain Unsafe Lead Levels

Sindoor -- a cosmetic powder sold in the United States and used during Hindu religious and cultural ceremonies -- may contain unsafe levels of lead, Rutgers University researchers warn. Researc…

Read the full story

Wednesday, September 20, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Research and Publications

Two-Year Data: TREMFYA™ (guselkumab) Achieves Consistent Rates of Skin Clearance in Moderate to Severe Plaque Psoriasis

New longer-term data from the open-label extension of the VOYAGE 1 trial demonstrate consistent rates of skin clearance with TREMFYA™ treatment through week 100 among patients with moderate…

Read the full story

Monday, September 18, 2017 | PracticalDermatology.com, Research and Publications

U.K Survey Reveals Eczema Treatment Knowledge Gap

Two thirds of UK eczema patients don’t understand that bacteria play a crucial role in their condition despite studies showing that Staphylococcus aureus is present on the skin in of more than 7…

Read the full story

Thursday, September 14, 2017 | PracticalDermatology.com, Research and Publications, JAK inhibitors

Lilly’s Baricitinib Performs Well in Phase 2 AD Study

Lilly’s experimental JAK inhibitor Baricitinib in combination with a mid-potency topical corticosteroid (TCS) significantly improved the signs and symptoms of moderate-to-severe atopic dermatiti…

Read the full story

Wednesday, September 13, 2017 | PracticalDermatology.com, Product Launches and Updates, Research and Publications

Vanda's Tradipitant Improves Itch and Disease Severity in AD Patients

Vanda Pharmaceuticals Inc.’s tradipitant improved the intensity of the worst itch patients experienced, as well as atopic dermatitis (AD) disease severity,  according to results from an eig…

Read the full story

Wednesday, September 13, 2017 | PracticalDermatology.com, Research and Publications, Psoriasis

IPC, Others Call for Creation of Worldwide Psoriasis Database

A new report calls for the creation of a web-based Global Psoriasis Atlas (GPA) database that will document the prevalence and incidence of psoriasis worldwide. The report, entitled "Global St…

Read the full story

Monday, September 11, 2017 | Phase 3/4 Trials, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Lilly to Present New Data for Olumiant® and Taltz® at EADV

Eli Lilly and Company will present Phase 2 safety and efficacy data evaluating Olumiant® (baricitinib) for the treatment of moderate-to-severe atopic dermatitis (Lilly and Incyte Corporation …

Read the full story
Load More